Drugs.com - New Drug Approvals

ANI Pharmaceuticals Announces FDA Approval for Expansion of Iluvien Label

BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Iluvien (fluocinolone acetonide...

Mar 14, 2025 - 23:15
 0
ANI Pharmaceuticals Announces FDA Approval for Expansion of Iluvien Label
BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Iluvien (fluocinolone acetonide...
Read More

Tags:

Previous Article

FDA Advises Consumers Not to Inhale Nitrous Oxide Products

Next Article

China Passenger Car Association CEO Warns Elon Musk Is Burning Up Consumer Deman...

Related Posts

FDA Approves Osenvelt (denosumab-bmwo), a Biosimilar to Xgeva

FDA Approves Osenvelt (denosumab-bmwo), a Biosimilar to...

Mar 5, 2025  0

Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo (axatilimab-csfr) 9 mg and 22 mg Vial Sizes

Incyte and Syndax Announce U.S. Food and Drug Administr...

Feb 9, 2025  0

FDA Approves Rapiblyk (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting

FDA Approves Rapiblyk (landiolol) for Atrial Fibrillati...

Feb 9, 2025  0